{"artifact_id":"wiki-clinical-trials-gm-csf-sargramostim-ad-nct04902703","artifact_type":"wiki_page","title":"GM-CSF Sargramostim Phase 2 (NCT04902703) - AD Immunotherapy","quality_score":0.5,"is_latest":1,"version_number":1,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{"related":21},"total_incoming":21,"outgoing_by_type":{"related":11,"mentions":25},"total_outgoing":36,"quality_trajectory":[],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":57,"is_well_supported":false,"is_controversial":false,"is_foundational":false}